Nagi Bioscience SA develops and manufactures an automated testing device that raises, feeds, and analyzes worms independently for the testing of molecules in pharmaceutical, chemical, and cosmetic companies. It offers Caenorhabditis elegans-on-chip, a tool that combines the use of organism for in vivo testing with a technological platform for its automated in vitro handling, culture, and analysis. The company’s product is used in toxicity testing, drug discovery, and anthelmintic testing applications. Nagi Bioscience SA is based in Lausanne, Switzerland.